Tugtepe H - Search Results

1

Cysteinyl 1 receptor antagonist montelukast, does not prevent peritoneal membrane damage in experimental chronic peritoneal dialysis model in rats.

Yucel SK, Arikan H, Tugtepe H, Cakalagaoglu F, Tuglular S, Akoglu E, Ozener C. Yucel SK, et al. Among authors: tugtepe h. Kidney Blood Press Res. 2014;39(6):648-57. doi: 10.1159/000368477. Epub 2014 Dec 19. Kidney Blood Press Res. 2014. PMID: 25571878 Free article.

2

Role of tyrosine kinase inhibition with imatinib in an encapsulating peritoneal sclerosis rat model.

Velioglu A, Tugtepe H, Asicioglu E, Yilmaz N, Filinte D, Arikan H, Koc M, Tuglular S, Kaya H, Ozener C. Velioglu A, et al. Among authors: tugtepe h. Ren Fail. 2013;35(4):531-7. doi: 10.3109/0886022X.2013.773915. Epub 2013 Mar 11. Ren Fail. 2013. PMID: 23473055 Free article.

3

Downregulation of the expression of bone morphogenetic protein 7 in experimental pyelonephritis.

Biyikli NK, Tugtepe H, Cakalagaoglu F, Ilki A, Alpay H. Biyikli NK, et al. Among authors: tugtepe h. Pediatr Nephrol. 2005 Sep;20(9):1230-6. doi: 10.1007/s00467-005-1927-4. Epub 2005 Jul 21. Pediatr Nephrol. 2005. PMID: 16034630

4

Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.

Tuğtepe H, Sener G, Cetinel S, Velioğlu-Oğünç A, Yeğen BC. Tuğtepe H, et al. Eur J Pharmacol. 2007 Feb 14;557(1):69-75. doi: 10.1016/j.ejphar.2006.11.009. Epub 2006 Nov 10. Eur J Pharmacol. 2007. PMID: 17173892

5

The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats.

Karadeniz Cerit K, Karakoyun B, Yüksel M, Özkan N, Cetinel Ş, Tolga Dağli E, Yeğen BÇ, Tuğtepe H. Karadeniz Cerit K, et al. Among authors: tugtepe h. J Pediatr Urol. 2013 Apr;9(2):174-83. doi: 10.1016/j.jpurol.2012.01.015. Epub 2012 Feb 26. J Pediatr Urol. 2013. PMID: 22373656

6

Collagen ultrastructure and TGF-beta1 expression preserved with aminoguanidine during wound healing in diabetic rats.

Yavuz D, Tuğtepe H, Cetinel S, Uyar S, Kaya H, Haklar G, Civelek S, Deyneli O, San T, Burçak G, Akalin S. Yavuz D, et al. Among authors: tugtepe h. Endocr Res. 2005;31(3):229-43. doi: 10.1080/07435800500373140. Endocr Res. 2005. PMID: 16392625

7

Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats.

Yıldız N, Alpay H, Tuğtepe H, Özdemir Kumral ZN, Akakın D, İlki A, Şener G, Ç Yeğen B. Yıldız N, et al. Among authors: tugtepe h. Int J Urol. 2015 Jun;22(6):598-603. doi: 10.1111/iju.12752. Epub 2015 Mar 25. Int J Urol. 2015. PMID: 25808602

8

Halofuginone Alleviates Burn-Induced Hepatic and Renal Damage in Rats.

Cerit KK, Karakoyun B, Yüksel M, Ercan F, Tuğtepe H, Dagli TE, Yeğen BÇ. Cerit KK, et al. Among authors: tugtepe h. J Burn Care Res. 2017 Jan/Feb;38(1):e384-e394. doi: 10.1097/BCR.0000000000000400. J Burn Care Res. 2017. PMID: 27388880

9

Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism.

Biyikli NK, Tuğtepe H, Sener G, Velioğlu-Oğünç A, Cetinel S, Midillioğlu S, Gedik N, Yeğen BC. Biyikli NK, et al. Among authors: tugtepe h. Peptides. 2006 Sep;27(9):2249-57. doi: 10.1016/j.peptides.2006.03.029. Epub 2006 May 16. Peptides. 2006. PMID: 16707192

10

Resveratrol improves ischemia/reperfusion-induced oxidative renal injury in rats.

Sener G, Tuğtepe H, Yüksel M, Cetinel S, Gedik N, Yeğen BC. Sener G, et al. Among authors: tugtepe h. Arch Med Res. 2006 Oct;37(7):822-9. doi: 10.1016/j.arcmed.2006.04.003. Arch Med Res. 2006. PMID: 16971220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters